Evaluation of access to care issues in patients with breast cancer.


Journal

Journal of medical economics
ISSN: 1941-837X
Titre abrégé: J Med Econ
Pays: England
ID NLM: 9892255

Informations de publication

Date de publication:
Historique:
pubmed: 16 12 2020
medline: 30 9 2021
entrez: 15 12 2020
Statut: ppublish

Résumé

System-level efforts have been deployed to improve oncology care and access while reducing utilization and costs. Understanding the nature of access to care from the perspective of patients themselves is an unmet need. This study examined access to care in a population of women with breast cancer and its relationship to overall patient satisfaction. Patients with breast cancer from six oncology clinics in five states completed a survey during routine office visits. Access to care (higher scores indicated increasing access barriers), overall patient satisfaction, and patient demographic/clinical characteristics were measured. The relationships between access (composite and factor scores) and satisfaction were assessed using multivariable analyses controlling for age (the only significant characteristic from bivariate analyses). A total of 180 patients completed the survey. Factor analysis of access to care items revealed an 8-factor measure - Insurance, Health System, Emotional, Holistic Treatment, Family Support, Knowledge/Understanding, Information Quality, and Financial Support - with high reliability (Composite: Cronbach alpha = 0.93; Factors: Cronbach alpha range = 0.85-0.91). Access composite score was moderately low (mean = 1.90), indicating an overall low level of access barriers, and overall patient satisfaction was high (mean = 4.59). The composite score ( Study sites were high functioning clinics and all, but one, are Oncology Care Model practices. Thus, the scope of access to care issues for patients of under-resourced clinics might not be well addressed. Access to care overall and by factor was significantly predictive of patient satisfaction with care. In addition, access to care factors varied across several demographic and clinical characteristics. Future strategies that address access to care challenges should consider these modifiable, patient-centric, and system-based issues.

Identifiants

pubmed: 33317379
doi: 10.1080/13696998.2020.1858580
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-45

Auteurs

Carolyn M Brown (CM)

Texas Center for Health Outcomes Research and Education (TxCORE), College of Pharmacy, The University of Texas at Austin, Austin, TX, USA.

Kristin M Richards (KM)

Texas Center for Health Outcomes Research and Education (TxCORE), College of Pharmacy, The University of Texas at Austin, Austin, TX, USA.

Yogesh Vohra (Y)

Texas Center for Health Outcomes Research and Education (TxCORE), College of Pharmacy, The University of Texas at Austin, Austin, TX, USA.

Chisom Kanu (C)

RTI Health Solutions, Research Triangle Park, NC, USA.

Laura Stevens (L)

Innovative Oncology Business Solutions, Albuquerque, NM, USA.

Rahul Sasane (R)

Cerevel Therapeutics, Boston, MA, USA.

Sanjeev Balu (S)

Novartis Pharmaceuticals, East Hanover, NJ, USA.

Barbara McAneny (B)

New Mexico Oncology Hematology Consultants, Albuquerque, NM, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH